Global Temperature-Controlled Packaging for Pharmaceutical Market Overview

Temperature Controlled Packaging for Pharmaceutical Market Size was valued at USD 10.1 billion in 2021. The temperature-controlled packaging for pharmaceutical market industry is projected to grow from USD 11.02 Billion in 2022 to USD 20.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.20% during the forecast period (2022 - 2030).

Temperature-controlled solutions are essential in maintaining blood or vaccines. Cold chain solutions are used in this regard for the pharmaceutical industry to cater to the growing demand among patients and rise of lifestyle diseases. The packaging solutions are designed to maintain temperature conditions during the supply chain.

The market is driven by strict regulations to enhance distribution methods of pharmaceutical goods. Research and development programs for enhancing packaging process can encourage market growth. Temperature-controlled drugs and vaccines are shipped in adherence to electromechanical or electronic temperatures with supportive logs documenting its proper storage. Development of new drugs and therapies can spur the demand of cold chain logistics.

COVID-19 Impact:

The COVID-19 pandemic has created a lucrative pocket for temperature-controlled packaging solution developers in the pharmaceutical industry. Guidelines outlined by health organizations for preservation of vaccines and drugs has led to development of containers and shippers capable of maintaining the vaccines integrity in spite of the container being exposed to ambient temperatures. Dry ice has been utilized for maintaining the thermal temperature of the sensitive vaccines.

Industry Trends:

Temperature-controlled packaging containers are being developed by keeping the sustainability factor in mind. They are being designed to limit its carbon dioxide emissions to adhere to quality standards and reduce the risks while delivering defective products. Logistics companies are integrating digital technologies for monitoring and tracking their products. For instance, Softbox has partnered with Pfizer in supply and distribution of COVID-19 vaccines with the help of a reusable ultra-low temperature insulated shipper.

Segmentation:

By product, the temperature-controlled packaging for pharmaceutical market has been divided into insulated shippers and insulated containers. This is due to rising investments in insulated packaging solutions. They offer effective packaging solutions for temperature sensitive and time-critical products. Insulated shippers are lightweight containers used in shipping of sensitive products. Development of reusable insulated shippers for distribution of low-temperature vaccines is likely to bolster segment demand.

Types of temperature-controlled packaging have been bifurcated into active systems and passive systems. The active systems segment controls the major share of the temperature-controlled packaging for pharmaceutical market. It is expected to remain highly attractive over the next couple of years. It is projected to surpass a market valuation of USD 5,000 Mn over the forecast period. Active systems are containers with temperature control systems which function on electricity. They are secure and assist with quick loading and unloading.

By temperature range, the market has been segmented into more than 20°C, Up to 10°C, and 10°C to 20°C. The up to 10°C segment is projected to exhibit a CAGR of 9.93% during the forecast period. It accounted for 48.20% market share in 2017. This is due to increasing usage of packaging solutions with temperature range of up to 10°C in high-risk products such as blood products, vaccines, insulins, and other protein-dense solutions.

On the basis of payload capacity, the market has been segmented into more than 150 L, 40-150 L, up to 10 L, 10-20 L, and 20-40 L. The up to 10 L segment currently accounts for the largest market share. It is expected to touch a market valuation of over USD 2,600 Mn over the forecast period.

By type of use, the market has been bifurcated into single use and reusable. The single-use segment is leading the market due to its disposable nature. It accounted for more than two-third of the market share in 2017. But the reusable segment is touted to deliver a sharp growth rate over the forecast period owing to sustainable measures taken by pharmaceutical packaging experts.

End-use industries of the market are pharmaceutical and clinical trial. The former segment will deliver a higher performance than the latter throughout the forecast period. In 2017, the pharmaceutical segment can exceed a value of USD 4,000 Mn. It can perform well owing to supply of drugs and blood to patients at hospitals and critical care centers.

Get Free Sample PDF Brochure:

https://www.marketresearchfuture.com/sample_request/7190

Regional Segmentation:

The temperature-controlled packaging for pharmaceutical market covers regions of North America, Europe, Asia Pacific (APAC), and Rest-of-the-World (RoW).

North America is expected to be highly lucrative for the market owing to various lifestyle diseases, large volume of patients, and large disposable income levels. Stringent safety policies pertaining to pharmaceutical products and a growing geriatric population can boost regional market demand. Trade agreements between countries and boom in international trade can augur favorably for the market.

APAC is deemed to be extremely lucrative owing to rise of infectious diseases and need for cold chain solutions for preserving vaccines. Recently, Envirotainer decided to establish a new station in India for transportation of COVID-19 vaccines. The new station is expected to host RAP e2 and RKN e1 containers and play a critical role in air freight solutions. Acquisitions are projected to be witnessed in the region as the market becomes consolidated.

Competitive Analysis:

The temperature-controlled packaging for pharmaceutical market is very competitive and marked by expansions and alliances.

Key players involved in the market are va-Q-tec AG, Pelican Bio Thermal, Storopack Hans Reichenecker GmbH, Cold Chain Technologies, Envirotainer AB, Sofrigam, KUEHNE + NAGEL INC., DHL International GmbH, United Parcel Service of America, Inc. (UPS), DB Schenker, Sonoco ThermoSafe,  and Softbox Systems Limited. Sonoco ThermoSafe is dominating the market with 5.2% market share. This is due to its large product portfolio of protective packaging, insulated slippers, and durable insulated containers. It is focusing its efforts on expansions and product developments for gaining customers. On the other hand, Storopack Hans Reichenecker GmbH has 3.8% market share with customized packaging solutions coupled with cushioning to deter any impact during road transport.

Industry News

American Airlines Cargo has partnered with CSafe Global and CargoSense for providing temperature-controlled packaging solutions to clients. Its successful trials have led to the company expanding its facilities to cities of Pittsburgh, Memphis, and Cincinnati.

Retention of Vaccine Integrity to Drive Demand in Global Temperature-controlled Packaging for Pharmaceutical Market

The global temperature-controlled packaging for pharmaceutical market is set to experience massive demand owing to heavy reliance on medicines and vaccines. The COVID-19 pandemic has boosted the market demand significantly owing to demand for temperature-controlled solutions. Imports and exports of vital drugs coupled with utilization of cold chain logistics can boost market growth.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com